CGRP blockade by galcanezumab was not associated with reductions in signs and symptoms of knee osteoarthritis in a randomized clinical trial
Autor: | Jin, Y. †, Smith, C. ‡, Monteith, D. †, Brown, R. †, Camporeale, A. §, McNearney, T.A. †, Deeg, M.A. †, Raddad, E. †, Xiao, N. ‖, de la Peña, A. †, Kivitz, A.J. ¶, Schnitzer, T.J. # |
---|---|
Zdroj: | In Osteoarthritis and Cartilage December 2018 26(12):1609-1618 |
Databáze: | ScienceDirect |
Externí odkaz: |